Royal Bank of Canada »

Mural Oncology shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Mural Oncology (MURA) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Mural Oncology

Tip: Access up to 7 years of quarterly data

All positions including Mural Oncology held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mural Oncology by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $33k 5.7k 5.87

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
UnitedHealth (UNH)
Bk Nova Cad (BNS)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 2000 Etf (IWM)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)

View all positions for Royal Bank of Canada

Top funds holding Mural Oncology

Westfield Capital Management Company
BlackRock
Vanguard Group
Newtyn Management
PRIMECAP Management Company
Citadel Advisors
Squarepoint Ops
Millennium Management
Hrt Financial
Artisan Partners Limited Partnership
Norges Bank Investment Management
Goldman Sachs Group
Nicollet Investment Management
Centiva Capital
Susquehanna International

View all funds holding Mural Oncology